Alejandro Tello

Dr. Alejandro Tello


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Eye
Verified
Journal Article
Closed access
ATAlejandro Tello
Alejandro Tello
TSTrevor Sherwin
Trevor Sherwin
ATAlejandro Tello
Alejandro Tello
JMJ Merayo
J Merayo
RBR Barrera
R Barrera
AAA Acera
A Acera

1 January 2021 in Experimental Eye Research
Verified
Journal Article
Closed access
YRYaron S. Rabinowitz
Yaron S. Rabinowitz
VGVirgilio Galvis
Virgilio Galvis
ATAlejandro Tello
Alejandro Tello
DRDaniela Rueda
Daniela Rueda
JGJuan Daniel García
Juan Daniel García

1 May 2016 in Medical Hypotheses
Verified
Journal Article
Closed access
VGVirgilio Galvis
Virgilio Galvis
PLPatricio López-Jaramillo
Patricio López-Jaramillo
ATAlejandro Tello
Alejandro Tello
YCYuly Andrea Castellanos-Castellanos
Yuly Andrea Castellanos-Castellanos
PLPaul A Camacho Lopez
Paul A Camacho Lopez
JMJesús Merayo-Lloves
Jesús Merayo-Lloves

26 June 2018 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
VGVirgilio Galvis
Virgilio Galvis
ATAlejandro Tello
Alejandro Tello
JOJohana Otero
Johana Otero
ASAndres A Serrano
Andres A Serrano
LGLuz María Gómez
Luz María Gómez
PLPatricio López-Jaramillo
Patricio López-Jaramillo
Purpose To determine the prevalence of refractive errors in Colombia and its relations with demographic and socioeconomic variables. Methods A cross-sectional study performed in 10 Colombian administrative districts (MIOPUR study), including children and adolescents from 8 to 17 years old and adults from 35 to 55 years old. Results 3608 individuals (100% of whom agreed to participate) were included. Prevalence estimates of refractive errors were: hyperopia 32.3% (95% CI 30.7 to 33.8), myopia 12.9% (95% CI 11.8 to 14.0), mixed astigmatism 2.8% (95% CI 2.2 to 3.3) and anisometropia 1.9% (95% CI 1.4 to 2.3). Prevalence of myopia in 15-year-old adolescents was 14.7%. In children and adolescents, the hyperopia prevalence decreased while myopia prevalence increased with age. In the adults group, the tendency was the contrary. Myopia prevalence reached 15.7% in urban and 9.2% in rural areas, and for hyperopia, the rates were 29.4% in urban and 36.1% in rural areas. In the multivariate analysis, living in an urban area significantly increased the risk of having myopia (OR: 1.45 (1.12 to 1.89); p<0.01). There were significant regional differences among diverse zones of the country. Conclusions Prevalence estimates of myopia and hyperopia in Colombia were found to be at an intermediate point compared with global data. In adults, myopia frequency was lower than in European and Asian studies. The prevalence of myopia increased during childhood and adolescence and was higher in middle-aged adults (35–39 years) than in older adults. On the other hand, hyperopia rates increased with age, findings that suggest a cohort effect. In the multivariate analysis, residence in urban areas and living in a medium-high socioeconomic status were linked to myopia.

1 August 2015 in Cornea
Verified
Journal Article
Closed access
VGVirgilio Galvis
Virgilio Galvis
ATAlejandro Tello
Alejandro Tello
RBRodrigo Barrera
Rodrigo Barrera
CNCamilo A. Niño
Camilo A. Niño

1 April 2017 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
VGVirgilio Galvis
Virgilio Galvis
ATAlejandro Tello
Alejandro Tello
AOAlvaro I Ortiz
Alvaro I Ortiz
LELuis C Escaf
Luis C Escaf
Corneal cross-linking (CXL) is an option that in the last decade has demonstrated its efficacy and safety in halting the progression of keratoconus (KCN) and other corneal ectasias. Its indication has been extended beyond the classic definition that required evidence of KCN progression, especially in the presence of some risk factors for a possible progression (particularly the younger age). However, the results can be still somewhat variable today. There are several protocols, each with its own advantages and disadvantages. Some predictors of CXL outcome have been identified. We will review the current knowledge on patient selection for CXL, its indications, and options in special cases (such as thin corneas).